Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
7.01
-0.18 (-2.44%)
Jan 22, 2025, 4:00 PM EST - Market closed
Mind Medicine (MindMed) Employees
Mind Medicine (MindMed) had 57 employees as of December 31, 2023. The number of employees increased by 9 or 18.75% compared to the previous year.
Employees
57
Change (1Y)
9
Growth (1Y)
18.75%
Revenue / Employee
n/a
Profits / Employee
-$1,715,825
Market Cap
513.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 57 | 9 | 18.75% |
| Dec 31, 2022 | 48 | 7 | 17.07% |
| Dec 31, 2021 | 41 | 19 | 86.36% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
MNMD News
- 4 weeks ago - MindMed to Be Added to the Nasdaq Biotechnology Index - Business Wire
- 5 weeks ago - MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) - Business Wire
- 6 weeks ago - MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress - Business Wire
- 6 weeks ago - MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) - Business Wire
- 7 weeks ago - MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy - Business Wire
- 7 weeks ago - MindMed Announces New Employee Inducement Grants - Business Wire
- 2 months ago - MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer - Business Wire
- 2 months ago - MindMed to Participate in Upcoming Investor Conferences - Business Wire